Last updated on November 2017

RTOG 0848: A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.


Brief description of study

RTOG 0848: A Phase III Trial Evaluating Both Erlotinib and Chemoradiation as Adjuvant Treatment for Patients with Resected Head of Pancreas Adenocarcinoma.

Detailed Study Description

For more information please visit: http://clinicaltrials.gov/ct2/show/NCT01013649?term=RTOG+0848&rank=1

Clinical Study Identifier: TX1849

Contact Investigators or Research Sites near you

Start Over

Patricia Green

Memorial Health University Medical Center
Savannah, GA USA